A 1999 clinical study that Merck & Co Inc (MRK.N) said was done to test side effects of its now-withdrawn painkiller Vioxx was done primarily to support a marketing campaign before its launch, according to researchers.
The real aim of the study, called ADVANTAGE, was to promote prescription of the new medicine when it became available -- a so-called "seeding" project -- U.S. researchers said on Tuesday.
"Documentary evidence shows that ADVANTAGE is an example of marketing framed as science," they wrote in the journal Annals of Internal Medicine.
Kevin Hill, a psychiatrist at McLean Hospital in Belmont, Mass., and colleagues said the findings showed how studies masquerading as clinical science could be used to bolster marketing plans.
Dr. Laurie Dill pointed to a large map in the hallway of Medical AIDS Outreach of...
An Ebola outbreak that has killed more than 670 people in Africa is now taking a...
